Average Co-Inventor Count = 5.98
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Lycera Corporation (23 from 36 patents)
2. Array Biopharma Inc. (18 from 329 patents)
3. Eli Lilly and Company (11 from 4,442 patents)
4. Merck Sharp + Dohme Corp. (8 from 2,405 patents)
5. University of Michigan (1 from 3,370 patents)
53 patents:
1. 11059796 - Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
2. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
3. 10611740 - Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
4. 10556898 - Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
5. 10532088 - Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
6. 10442798 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
7. 10421751 - Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
8. 10392350 - N-substituted pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
9. 10377768 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
10. 10364237 - Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
11. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
12. 10208061 - Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
13. 10189777 - Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
14. 10112935 - Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
15. 10017482 - Mitotic kinesin inhibitors and methods of use thereof